Healthcare Market Research Worldwide
Drive Confident Launch Decisions with Strategic Intelligence
Market research for pharma launch teams, from patient journey mapping to physician segmentation, in 75+ countries.
Trusted by Top 15 Global Pharma Companies
APLUSA is a global partner to pharmaceutical and biotech teams, delivering decision-ready intelligence to prepare confident product launches worldwide.
Understand the full market landscape before you act
- Comprehensive market analysis
- Patient funnel and journey analysis
- Identification of unmet needs and barriers
Measure opportunity before investing resources
- Market sizing & market modeling
- Demand studies across segments
- Scenario-based forecasting support
Assess brand performance intelligence
- Brand positioning and message testing
- Competitive benchmarking and differentiation analysis
- Scenario-based launch performance forecasting
Inform brand positioning to prepare G2M
- Physician segmentation
- Patient profiling
- Competitive intelligence
APLUSA in Figures
1+
Countries covered worldwide
1
Years of trusted insights
1+
Nationalities across our team
1+
Therapeutic areas of expertise
Hybrid Methodologies to Accelerate Your Decisions
Leveraging real-world patient data, our Therapy Intelligence™ solution goes beyond syndicated studies to deliver fast, robust, multi-country insights, whether used standalone or integrated with custom methodologies.
Decision-Ready Intelligence Access
Data-heavy analysis designed to support confident strategic and commercial decisions.
AI-Powered Forecasting
Forward-looking projections and market scenarios supported by advanced AI models.
Interactive Dashboards
Explore insights through intuitive dashboards built for pharma commercial teams.
Connected Data Streams
Standardized and connected datasets providing macro insights and market benchmarks.
Industry Presence & Global Engagement
APLUSA actively contributes to the global healthcare ecosystem and regularly exhibits in leading international congresses.
Recent Scientific Contributions
2026
·
Urothelial Carcinoma
Real-World Data On Patients’ Characteristics Guiding Physicians’ Choice Of First-line Treatment For Advanced Urothelial Carcinoma: Is There Still A Place For Platinum-based Chemotherapy?
ASCO Genitourinary Cancers Symposium 2026
2025
·
Multiple Myeloma
Real-world Sequencing of Anti-bcma Car T-cells and Bispecific T-cell Engagers in Relapsed/refractory Multiple Myeloma: a Multi-country Analysis
ASH 2025, Orlando
2025
·
Iron Deficiency
Iron deficiency treatment pathway in Italy: patients’ perceptions of diagnosis and treatment.
Journal of Comparative Effectiveness Research
Built for High-Stakes Pharmaceutical Decisions
- Strict confidentiality protocols and secure data infrastructures
- Experience supporting global and US-based regulatory environments
- GDPR-aligned and compliance-conscious research processes
- Senior-led teams with strategic and therapeutic expertise
Connected Worldwide
Our global presence ensures local insights and seamless collaboration, no matter where you are.
New York
445 Park Avenue, 9th Floor
New York, NY 10022
USA
Lyon
222 cours Lafayette
69003 Lyon
France
+33 478 622 323
Paris
159 rue Gallieni
92641 Boulogne Cedex
France
+33 478 622 323
London
156 Blackfriars Road
London SE1 8EN
United Kingdom
+44 20 7073 2666
